CHEK NASDAQ
Check-Cap Ltd.
1W: -1.7%
1M: +13.4%
3M: -21.9%
1Y: +189.4%
3Y: -41.2%
5Y: -73.8%
$1.86
Last traded 2025-12-18 — delisted
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
#65
of 91
Medical - Diagnostics & Research
Technical Signal Map
0 Bullish
1 Neutral
2 Bearish
Peer Comparison
| Symbol | Mkt Cap | P/E | ROE % | ROIC % | Net Mgn % | Rev Grw % | Piotroski | Signal | 1Y Ret % |
|---|---|---|---|---|---|---|---|---|---|
| CHEK Check-Cap Ltd. | $10M | -0.4 | -226.2 | 1298.3 | — | — | 2 | N/A | 189.4 |
| ROSGQ Rosetta Genomics Ltd. | — | -0.0 | -44.3 | -306.4 | 136.0 | — | 1 | BEARISH | 0.0 |
| TOMDF Todos Medical Ltd. | — | -0.0 | 89.6 | -253.6 | -355.9 | -37.1 | 3 | BEARISH | -90.0 |
| CHEK Check-Cap Ltd. | $10M | -0.4 | -226.2 | 1298.3 | — | — | 2 | N/A | 189.4 |
| ROSGQ Rosetta Genomics Ltd. | — | -0.0 | -44.3 | -306.4 | 136.0 | — | 1 | BEARISH | 0.0 |
| TOMDF Todos Medical Ltd. | — | -0.0 | 89.6 | -253.6 | -355.9 | -37.1 | 3 | BEARISH | -90.0 |
Profile Radar
Valuation vs Profitability
Performance Comparison
Industry Market Share
CHEK vs Benchmarks
ROIC
P/E Ratio
ROE
Piotroski F